What is Qumata?
Qumata is at the forefront of transforming the underwriting landscape for life and health insurance providers. By leveraging digital data, the company accurately calculates the risk of over 800 conditions, including additional mortality and morbidity risks. This innovative approach not only enhances the customer experience by reducing the need for extensive questionnaires and doctor visits but also empowers insurers to unlock new revenue streams through more precise risk assessment and improved operational efficiencies.
How much funding has Qumata raised?
Qumata has raised a total of $23M across 1 funding round:
Series A
$23M
Series A (2022): $23M with participation from MMC Ventures
Key Investors in Qumata
MMC Ventures
MMC Ventures is a venture capital firm that focuses on funding and scaling technology companies transforming today's markets. They specialize in early-stage investments, providing deep understanding of technology and business models to be effective partners.
What's next for Qumata?
The substantial enterprise-level funding Qumata has garnered signals a strong market validation and provides the necessary capital for significant scaling and product development. This strategic investment is expected to fuel Qumata's expansion into new markets, further enhance its proprietary risk assessment technology, and solidify its position as a leader in insurtech innovation. The company is poised to deepen its impact on the insurance industry by enabling more accurate, efficient, and customer-centric underwriting.
See full Qumata company page
